Key result
Sympathetic dysautonomia in CFS links to markedly lower quality of life versus balanced autonomic phenotypes.
Why the study?
The characteristics of autonomic subgroups in patients with Chronic Fatigue Syndrome and their association with illness severity were not well defined.
Cross-Sectional (n=102)
No
Patients with Chronic Fatigue Syndrome can be clustered into distinct autonomic phenotypes, with sympathetic dysautonomia correlating with greater illness severity and lower quality of life.
Answers are grounded in this paper and cite their sources.
Autonomic phenotyping may stratify CFS severity; hypothesis-generating cross-sectional association requires prospective validation before clinical adoption.
In this study we set out to define the characteristics of autonomic subgroups of patients with Chronic Fatigue Syndrome (CFS). The study included 131 patients with CFS (Fukuda criteria). Participants completed the following screening symptom assessment tools: Chalder Fatigue Scale, Fatigue Impact Scale, Fatigue Severity Scale, Epworth Sleepiness Scales, the self-reported Composite Autonomic Symptom Scale. Autonomic parameters were measured at rest with a Task Force Monitor (CNS Systems) and arterial stiffness using an Arteriograph (TensioMed Kft.). Principal axis factor analysis yielded four factors: fatigue, subjective and objective autonomic dysfunction and arterial stiffness. Using cluster analyses, these factors were grouped in four autonomic profiles: 34% of patients had sympathetic symptoms with dysautonomia, 5% sympathetic alone, 21% parasympathetic and 40% had issues with sympathovagal balance. Those with a sympathetic-dysautonomia phenotype were associated with more severe disease, reported greater subjective autonomic symptoms with sympathetic over-modulation and had the lowest quality of life. The highest quality of life was observed in the balance subtype where subjects were the youngest, had lower levels of fatigue and the lowest values for arterial stiffness. Future studies will aim to design autonomic profile-specific treatment interventions to determine links between autonomic phenotypes CFS and a specific treatment.
No takes yet. Share an insight, caveat, or question.
Słomko et al. (2020) conducted a cross-sectional in Chronic Fatigue Syndrome (n=102). Sympathetic with dysautonomia phenotype vs. Balanced autonomic phenotype was evaluated on Quality of life (Quality of Life Scale) (Cohen's d 0.8, 95% CI 0.2-1.4, p=0.04). In patients with Chronic Fatigue Syndrome, a sympathetic-dysautonomia phenotype was associated with lower quality of life compared to a balanced autonomic phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: